Atlas Trials

DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer

Clinical trial NCT05728814 · UNKNOWN

Trial details

NCT number
NCT05728814
Sponsor
Grupo Español de Investigación en Cáncer de Ovario
Status
UNKNOWN
Study type
OBSERVATIONAL
Endometrial Cancer
Start date
2023-03-07
Primary completion
2024-04-12
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.